AstraZeneca Booster Shot Generates Strong Immune Response Against Variants Including Omicron

AstraZeneca says early trial findings support the shot’s use as a booster no matter the shot used for primary vaccination.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive